PRF Technologies (PRFX) Treasury Shares (2019 - 2020)
PRF Technologies' (PRFX) quarterly Treasury Shares came in at $3.0 million in Q4 2020, little changed YoY from $3.0 million in Q1 2020, and little changed on a QoQ basis from $3.0 million in Q2 2020.
PRF Technologies (PRFX) Treasury Shares (2019 - 2020) Analysis & Trends
PRF Technologies (PRFX) has 2 years of Treasury Shares data on file, last reported at $3.0 million in Q4 2020.
- Quarterly Treasury Shares changed 0.0% year-over-year to $3.0 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $3.0 million (changed 0.0% YoY) and the FY2020 annual result came in at $3.0 million, changed 0.0% from the prior year.
- Treasury Shares steadied at $3.0 million in Q4 2020, from $3.0 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $3.0 million in Q4 2019 to a low of $3.0 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 19.00 Mn |
| 10 | PRF Technologies | 647,973.00 | -3.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.95 Mn |
| Dec 31, 2020 | 2.95 Mn |
| Jun 30, 2020 | 2.95 Mn |
| Jun 30, 2020 | 2.95 Mn |
| Dec 31, 2019 | 2.95 Mn |
| Dec 31, 2019 | 2.95 Mn |